The observation was initially surprising, because mTOR inhibition has been shown to have broad applicability to many types of cardiomyopathies [18,28,33,34] and mTORC1 signaling was obviously activated in our RagCS75Y cardiomyopathy models. The gene discussed is MTOR; the disease is cardiomyopathy.